Advertisement
Data Points: Beware of skin cancer during the dog days of summer

Data Points: Beware of skin cancer during the dog days of summer

By Modern Healthcare  |  July 14, 2018

The dog days of summer have arrived—running from July 3 to Aug. 11, according to the Old Farmer's Almanac. The 40-day stretch typically coincides with the hottest days of the year. Perfect for sitting by the pool, lake or ocean. But don't forget that sunscreen, or better yet, head-to-toe...

HHS faces tight deadline to reunite migrant kids with parents

HHS faces tight deadline to reunite migrant kids with parents

By Susannah Luthi  |  July 05, 2018

HHS Secretary Alex Azar said his department would meet two court-ordered deadlines to reunite immigrant children with their parents in a process that highlights the escalating cost and complexity of the inter-department immigration system.

CDC says more routine HIV screening would reduce new infections

CDC says more routine HIV screening would reduce new infections

By Steven Ross Johnson  |  June 26, 2018

About half of individuals considered to be at high risk for contracting HIV reported they were not offered testing by their physicians during a clinical visit, which experts say has hindered efforts to reduce the number of new infections.

Planned Parenthood looks to prevent Title X funding changes in court

Planned Parenthood looks to prevent Title X funding changes in court

By Virgil Dickson  |  June 21, 2018

Planned Parenthood and the National Family Planning & Reproductive Health Association asked a federal judge to stop HHS from changing its funding strategy for Title X grants. They argued the change was illegal as it was not done through a rulemaking.

Data Points: Suicide rates on the rise in the U.S.

Data Points: Suicide rates on the rise in the U.S.

By Modern Healthcare  |  June 16, 2018

The high-profile deaths this month of celebrity designer Kate Spade and TV personality Anthony Bourdain pushed suicide into the national spotlight. Suicide is the 10th leading cause of death in the nation.

Insurer denials for hepatitis C treatment remain high

Insurer denials for hepatitis C treatment remain high

By Shelby Livingston  |  June 07, 2018

Despite the availability of hepatitis C drugs capable of curing most patients, public and private health insurers denied treatment for more than a third of patients whose doctors prescribed the drugs between 2016 and April 2017, according to a study.

Advertisement
X

Subscribe and SAVE 50%

View our best offer
Subscribe to Print